
Injectable chemical therapy restores light sensitivity in blind patients
Key Takeaway:
Intravitreal photoswitch therapy, currently in early trials, shows promise in safely improving light response for patients with advanced retinitis pigmentosa.
What this means for you
This early research shows promise for retinitis pigmentosa, but it's not yet available in clinics. It may take years before it's ready. Continue with your current care and consult your doctor for advice.
Citation:
Nature Medicine - AI Section, 2026. DOI: s41591-026-04317-6 Read article →
